Omalizumab may protect allergic patients against COVID-19: A systematic review

Omalizumab may protect allergic patients against COVID-19: A systematic review

Omalizumab, which downregulates the immunoglobulin E (IgE) receptor site on plasmacytoid dendritic cells and thereby increases interferon-α (INF-α) production, may shorten the duration of viral infections by enhancing the antiviral immunity.A systematic review was conducted to investigate whether pr...

Full description

Bibliographic Details
Main Authors: Daniele Giovanni Ghiglioni, MD, ET Laura Cozzi, MD, Riccardo Castagnoli, MD, PhD, Gaia Bruschi, MD, Laura Maffeis, MD, Paola Giovanna Marchisio, MD, Gian Luigi Marseglia, MD, Amelia Licari, MD, PhD
Format: Article
Language:English
Published: Elsevier 2023-02-01
Series:World Allergy Organization Journal
Subjects:
COVID-19
Interferon
IFN-Alpha
Omalizumab
SARS-CoV-2
Online Access:http://www.sciencedirect.com/science/article/pii/S1939455123000017

Internet

http://www.sciencedirect.com/science/article/pii/S1939455123000017

Similar Items